Actinobacillus actinomycetemcomitans leukotoxin permeabilized the plasma membrane of HL-60 promyelocytic leukemia cells, resulting in colloid osmotic lysis. These events were associated with efflux of 51chromium (from prelabeled cells), influx of propidium iodide, and ultrastructural evidence of cellular damage. Target cell lysis was inhibited by procedures which may interfere with the initial interaction of the toxin with the plasma membrane. For example, washing cultures (to dilute and remove toxin) or the addition of monoclonal antibodies (to neutralize toxin) or trypsin (to inactivate toxin) limited lysis when undertaken within the first 5 min of the reaction. The extent of injury was also diminished when radiolabeled HL-60 cells were exposed to toxin in the presence of unlabeled, toxin-sensitive cells (e.g., HL-60 cells or human neutrophils) or certain toxin-resistant target cells (e.g., human K562 erythroleukemia cells). This suggests that the association of the toxin with the cell membrane may not be sufficient to cause lysis without activation of additional effector mechanisms. The addition of specific trivalent (e.g., La3+) or divalent (e.g., Ca2+ and Zn2+) cations to toxin-treated cells appeared to enhance their capacity to repair or minimize the extent of toxin-mediated membrane damage. Depending on size, certain saccharides served as osmotic protectants: maltose almost completely inhibited radiolabel release, while smaller molecules provided correspondingly less protection. The results imply that the leukotoxin has membranolytic activity, producing pores in target cells with a functional diameter approximately the size of maltose (0.96 nm).
Actinobacillus actinomycetemcomitans synthesizes a potent polypeptide toxin (Mr 116,000) which destroys neutrophils and monocytes of humans, the great apes, and most old-world monkeys (23, 24) . Human myelomonocytic and certain lymphocytic leukemia cell lines are also susceptible targets (20) . By contrast, other human cells or leukocytes of other species are not killed by the leukotoxin. The molecular basis for the cytolytic properties of the toxin and its cellular and species specificities are not completely understood. Preliminary studies indicate that the cell membrane represents the primary site of attack of the toxin (20, 22, 23) . The leukotoxin gene has been cloned (12) (13) (14) , and DNA sequence analyses indicate that it shares extensive homology with other pore-forming bacterial cytolysins: Pasteurella hemolytica leukotoxin (15, 21) and Escherichia coli alphahemolysin (10) . While distinct differences were noted between the deduced amino acid sequence of the A. actinomycetemcomitans leukotoxin gene and that of the related pore-forming toxins, no obvious explanation for the unique specificities of the leukotoxin could be discerned. The purposes of the present investigation were to obtain information on the kinetics and nature of the interaction between purified leukotoxin and susceptible target cells and to study the effects of cations and osmotic protectants (saccharides) on the cytolytic process.
MATERIALS AND METHODS
Preparation of A. actinomycetemcomitans leukotoxin. Leukotoxin was extracted with polymyxin B from overnight cultures of A. actinomycetemcomitans JP2 and purified by ion-exchange and molecular-sieve chromatography essen-* Corresponding author. tially as described by Tsai et al. (24) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the purified native toxin revealed a protein doublet (Mr 116,000). Toxin was lyophilized, stored at -70°C, and reconstituted with 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (pH 7.4) containing 150 mM Na+, 5 mM K+, 1.29 mM Ca2 , 1.2 mM Mg2 , and 155 mM Cl prior to use to provide a preparation containing 40 ng of protein per ml. Protein concentration was determined by the Bradford procedure, using bovine plasma albumin as the standard (6) .
HL-60 target cells. Human promyelocytic HL-60 leukemic cells were used as the principal leukotoxin-sensitive target cells in this study and were maintained in stationary suspension cultures in RPMI 1640 (GIBCO Laboratories, Grand Island, N.Y.) containing 10% horse serum (preheated at 56°C, 30 min) and 1% glutamine as described before (20) .
Other target cells. Human neutrophils (PMNs) and erythrocytes were isolated from heparinized blood by sequential Hypaque-Ficoll density centrifugation and sedimentation in dextran (24) . Rabbit peritoneal exudate PMNs were obtained 4 h after intraperitoneal injection of 250 ml of saline containing 0.1 g of shellfish glycogen (cells kindly provided by Sally Zigmond, University of Pennsylvania). Human K562 erythroleukemia and murine SP2 myeloma cell lines were maintained as described for HL-60 cells.
Measurement of 51Cr release from target cells. HL-60 cells were labeled with 51Cr as outlined by Simpson et al. (20) with minor modifications. In brief, 5 x 107 washed cells were suspended in 1 ml of phosphate-buffered saline (0.15 M; pH 7.4) and incubated (15 min, 37°C) with 0.5 mCi of 51Cr (as sodium chromate; Dupont, New England Nuclear Research Products, Boston, Mass.). Following washing by centrifugation to remove free label, 5 x 105 cells were distributed into round-bottom chambers of 96-well microculture plates (Falcon 3915; Becton Dickinson Labware, Lincoln Par, N.J.) containing leukotoxin and various reagents in a total of 225 ,ul of HEPES buffer supplemented with 0.1% gelatin. Incubations were carried out in triplicate at 37°C in 5% C02-95% air for 45 min; individual experiments were repeated on at least three separate occasions. Following sedimentation of the cells, the amount of radiolabel released into 100 ,ul of the culture supernatants was measured by gamma spectroscopy. Total available label was determined by lysis of cultures in 0.1% Triton X-100 and ranged from 2 x 104 to 3 x 104 cpm/100-,ul sample. Unless indicated otherwise, cells were exposed to a 50% lethal dose (LD50) of leukotoxin (2 ng of protein). Cells placed in buffer without leukotoxin or exposed to heat-inactivated (65°C, 30 min) toxin released <10% of the total available label.
Measurement of propidium iodide influx into target cells. The influx of propidium iodide into toxin-treated cells was measured by adaptations of the procedure described by Bhakdi et al. (4) . Intact cell membranes are almost impermeable to propidium iodide, but the dye enters permeabilized cells and binds to nucleic acids as reflected by an increase in cellular fluorescence. Washed HL-60 cells (1.5 x 106) were suspended in HEPES buffer (total volume of 2.0 ml without gelatin) containing 4 ,ug of propidium iodide (Sigma Chemical Co., St. Louis, Mo.) per ml and various concentrations of leukotoxin for up to 30 min. Fluorescence was continuously recorded at 37°C in stirred suspensions in a Spex Fluorolog (Spex Industries, Edison, N.J.) at an emission wavelength of 585 nm and an excitation wavelength of 488 nm. Results are expressed as percent change from base line prior to the addition of toxin to the cultures.
Transmission electron microscopy. HL-60 cells (5 x 106) in 1.0 ml of HEPES buffer (without gelatin) were exposed to toxin (2 ng) for 15 min at 37°C in 5% C02-95% air. Cultures were fixed by the addition of OS04 (final concentration, 1%, vol/vol) in HEPES buffer and processed for electron microscopy as described previously (20) .
"Cold" target cell inhibition assays. 5"Cr-labeled HL together with toxin and cations for 10 min at 37°C, washed by centrifugation, and suspended in buffer alone for an additional 30 min at 37°C. Radioactivity was measured in culture supernatants at both 10-and 30-min intervals and combined to provide the total 51Cr released from the cells.
Effects of osmotic protectants on cytotoxicity. 5"Cr-labeled HL-60 cells were allowed to equilibrate (15 min, 37°C) with various concentrations (5 to 100 mM) of selected osmotic protectants prior to the addition of leukotoxin (LD50; total exposure time to leukotoxin, 45 min). Saccharides (purchased from Sigma) were dissolved in HEPES buffer and included the following: inulin (mass, >3,000 daltons [Da]; molecular diameter, 2.8 nm); maltose (mass = 342 Da; molecular diameter, 0.96 nm); glucosamine (mass = 216 Da); galactose (mass = 180 Da); fucose (mass = 164 Da); or arabinose (mass = 150 Da; molecular diameter, 0.62 nm) (for estimation of molecular size, see reference 18). Experiments to determine whether the effects of the saccharides on cytolysis were reversible were performed as described for the cation studies (see above).
Neutralization of leukotoxin by monoclonal antibody. A hybridoma culture supernatant (LT107A3A3) with toxin neutralizing activity was produced and characterized as described previously (9) . Supematants were concentrated 10-fold by membrane filtration, dialyzed, and lyophilized. Following reconstitution with distilled water, 10 ,ul of the preparation was added to HL-60 suspensions prior to (10 min), simultaneously with, or at various intervals after exposure to leukotoxin. Supernatants from hybridoma cultures producing antibodies of unrelated specificities were processed in a similar fashion and used as controls.
Inactivation of leukotoxin by trypsin. Leukotoxin can be inactivated by specific proteolytic enzymes (24) . In the present experiments, trypsin (1 ,ug/ml; Sigma) was added to cell cultures simultaneously with or at various intervals after exposure to an LD50 of leukotoxin. RESULTS Effects of A. actinomycetemcomitans leukotoxin on HL-60 cells. As described earlier, leukotoxin induces dose-dependent cytolytic release of 51Cr from prelabeled HL-60 cells (20) . In the present investigation, cultures of 51Cr-labeled cells were exposed to an LD50 of toxin (2 ng); this provoked label release within 5 to 15 min, and approximately 50% of the available 51Cr was discharged by 45 min. The influx and fluorescence of propidium iodide into target cells were used as additional indicators to study the kinetics of cellular injury. Dose-and time-dependent fluorescence of the dye was observed beginning within 5 to 15 min after the addition of leukotoxin (Fig. 1 (Fig.  3a) . Similarly, unlabeled, toxin-sensitive human PMNs inhibited target cell lysis (Fig. 3a) . Unlabeled (Fig. 4) . Preinc influx of propi OXIN (ng) modulating the extent of toxin injury within the initial 2.5 ) / min of the response (Fig. 2d, 5 , and 6). Supernatants from p 0.6 ng°control hybridoma cultures had no effect on the reaction (not illustrated (Fig. 7) . By contrast, larger molecules provided inx of propidium iodide into HL-60 cells exposed to creasing protection depending on their size: inulin totally mukotoxin. HL-60 cells were incubated with various inhibited 51Cr release; maltose, >95%; glucosamine, -70%; Af leukotoxin (0.6 to 10 ng) at 37°C for 30 min in the galactose, -40%. Glucose had no effect on the cytolytic pidium iodide. Fluorescence of the dye was moniresponse (not shown). Inhibition of 5"Cr release by sacchasly.
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Within the concentrations tested, Mg2+ did not alter the course of the cytolytic reaction (Fig. 4) . Cells preincubated in Ca2+-free HEPES buffer or in the presence of 5 to 10 mM EGTA {[ethylenebis(oxyethylenenitrilo)]tetraacetic acid} were still susceptible to lysis (not shown). Cells preincubated with cations but washed prior to the addition of toxin were no longer protected. Protection was also abrogated when cultures were washed within 10 min after exposure to toxin in the presence of cations and then suspended in buffer alone for an additional 30 min (not shown).
Ultrastructural studies provided morphological confirmation of the protective influence of Ca2+ on the cytolytic response (Fig. 2b) . Under these conditions, the integrity of the majority of cells appeared to be preserved. Similar impressions were obtained with Zn2'-protected cultures, whereas obvious cytopathic alterations were still observed in cells exposed to toxin in the presence of Mg2+ (not illustrated). Inhibition of cytotoxicity by cations, monoclonal antibodies, or trypsin added to target cells after exposure to leukotoxin. In these experiments, cations, toxin-neutralizing monoclonal antibodies, or trypsin was added to cultures at various intervals after HL-60 cells were exposed to leukotoxin. The purpose was to compare the effectiveness of these agents in limiting or reversing the course of the cytolytic response after it had been initiated by the toxin. As indicated above, cations added to cultures prior to toxin provided significant protection (Fig. 4) ; polyclonal or monoclonal antibodies or trypsin also inhibit cell death when added before toxin (9, 20, 24) .
Monoclonal antibody against the toxin was effective in DISCUSSION A. actinomycetemcomitans leukotoxin produces rapid and profound disturbances in HL-60 target cells, altering the permeability properties of the cell membrane, leading to colloid osmotic lysis. This was reflected by the progressive efflux of 51Cr from and the influx and fluorescence of propidium iodide in poisoned cells. In addition, cellular disintegration, associated with disruption and denudation of the plasma membrane, was documented at the ultrastructural level. These, as well as other findings (see below), support the concept that the leukotoxin acts as a membranolytic agent.
Results of experiments that used unlabeled target cells to compete with 51Cr-labeled HL-60 cells for leukotoxin indicated that the leukotoxin recognizes and associates with determinants on the cell membrane. Decreased radioisotope release was observed when labeled HL-60 cells were exposed to toxin in the presence of unlabeled, toxin-sensitive HL-60 cells or human PMNs. Under these conditions, unlabeled cells compete for toxin; consequently, labeled target cells are protected to varying degrees as reflected by a reduction in the amount of 5"Cr discharged into the culture supernatants. Certain toxin-resistant cells (i.e., human erythrocytes or rabbit PMNs) did not compete for toxin, while others (human K562 erythroleukemia cells or murine SP2 cells) were good competitive inhibitors of the cytolytic response. It would appear that the toxin associates with or "binds" to components on the cell membrane, but this does not invariably lead to cell lysis. It is possible that different Ca2' and then exposed to leukotoxin for 15 min. Under these circumstances, the cells were protected against the leukotoxin and their appearance was similar to control cultures placed in buffer alone or exposed to heat-inactivated leukotoxin. Arrows point to mitochondria. Magnification, x7,000. (c) HL-60 cells were preincubated with maltose and then exposed to leukotoxin. No protection against the toxin is evident: this cell is swollen; a large segment of the plasma membrane has disappeared; and cytoplasmic organelles are being discharged into the extracellular medium. Magnification, x7,000. surface moieties are involved in the initial binding of toxin in susceptible and nonsusceptible targets, causing lysis in the former but not the latter. Alternatively, subsequent to initial binding, the toxin may need to interact with other membrane constituents or undergo conformational changes to attack the membrane. Toxin-resistant cells may lack necessary determinants to support or trigger these secondary events. It is also conceivable that certain resistant cells may be able to defend themselves against the toxin by limiting or repairing damaged segments of the membrane before irreversible alterations have occurred. Experiments were carried out to begin to explore some of these possibilities.
Procedures which probably interfere with toxin binding to the cell membrane, including washing the cultures or adding to inhibit cytolysis by 50% were as follows: La3", 0.05 mM; Zn2+, 0.4 mM; Ca2", 6 mM; Co2", 6 mM; Mn'+, 15 mM; Ba2", 30 mM. Mg2" did not inhibit cellular injury.
antitoxin antibodies or trypsin, proved effective in limiting cellular injury when applied within the first 5 min of the reaction. It is possible that antibody or trypsin may also alter domains on the leukotoxin that are responsible for perturbing the membrane. Antibody or trypsin may be inadequate beyond the first 5 min because the toxin may become "inaccessible" to either agent (for instance, by inserting into the plasma membrane). Also, at some point in the development of membrane injury functional leukotoxin may no longer be required to sustain the cytolytic process.
When added to HL-60 cells prior to Actinobacillus leukotoxin, certain trivalent or divalent cations prevented cell (19) . If the leukotoxin produces pores or channels in the membrane, cations may conceivably promote closure of these structures. This idea has been advanced to account for protection afforded by Ca2" or Zn2+ against perforin (3) and staphylococcal alpha-toxin (2). Finally, if oligomerization of the leukotoxin is necessary for the expression of cytolytic activity, cations may influence membrane fluidity and lateral movement of toxin monomers in the membrane. This may explain how Ca2+ impairs the formation of oligomers of staphylococcal alpha-toxin in target cell membranes (11) .
Results of experiments with osmotic protectants reinforce the concept that the leukotoxin produces pores or channels in target cell membranes. In the presence of osmotic protectants, leukotoxin still associated with target cells; removal of free saccharides by washing was followed by the release of 51Cr as in unprotected cells. Osmotic protection did not prevent membrane permeabilization (influx of propidium iodide) or ultrastructural cellular injury. Thus, protective saccharides remained in the extracellular medium to counterbalance the colloid-osmotic pressure of intracellular proteins (including radiolabeled macromolecules) which failed to leak out of the cells. Similar findings have been documented with several other pore-forming agents (7, 8, 16) . Since 51Cr release from prelabeled cells was almost totally inhibited by maltose and only partially affected by glucosamine and galactose, we estimate that the leukotoxin produces membrane pores with a molecular diameter approximating that of maltose, i.e., 0.96 nm.
The approximation for the size of the Actinobacillus toxin lesion is remarkably similar to that calculated for the P. haemolytica leukotoxin (-0.9 nm; 7), which kills bovine leukocytes and shares extensive homology with the Actinobacillus leukotoxin. Interestingly, the E. coli hemolysin, which displays substantial homology with both the Actinobacillus and Pasteurella leukotoxins (15, 21) , produces significantly larger transmembrane pores in erythrocytes (-3 nm; 5). While subtle variations in the molecular structures of the three toxins may be relevant in accounting for differences in pore size, the diameter of the lesion may also be influenced by the reparative capacity of the target cell. In comparison to nucleated cells, for example, erythrocytes seem to be limited in their ability to repair complementdamaged membranes; this may account for their enhanced sensitivity to terminal complement peptides when compared with nucleated cells (19) .
In summary, the A. actinomycetemcomitans leukotoxin associates with sensitive as well as certain nonsensitive target cells. Therefore, it is unlikely that specific toxinbinding sites exist exclusively in the former but not in the latter. After associating with the membrane, the leukotoxin probably triggers a series of changes that ultimately lead to overt membrane damage; these effector mechanisms may not be activated in nonsensitive target cells. Since cations may modulate cytotoxicity by influencing the reparative functions of toxin-injured membranes, this invites speculation on whether relative differences in the reparative potentials of cells play a role in distinguishing between toxinsensitive and toxin-resistant targets. These issues are VOL. 58, 1990 on November 6, 2017 by guest http://iai.asm.org/ subjects of on-going studies in our laboratory to learn more about the pathobiology of this intriguing molecule.
